Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,208 | 272 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $905.09 | 41 | $0 (2023) |
| Novo Nordisk Inc | $586.31 | 42 | $0 (2022) |
| Lilly USA, LLC | $416.85 | 29 | $0 (2023) |
| PFIZER INC. | $329.19 | 22 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $229.37 | 14 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $160.23 | 13 | $0 (2021) |
| Amarin Pharma Inc. | $157.43 | 11 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $150.61 | 11 | $0 (2020) |
| GlaxoSmithKline, LLC. | $149.37 | 10 | $0 (2022) |
| Astellas Pharma US Inc | $139.18 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $225.14 | 14 | Lilly USA, LLC ($135.24) |
| 2022 | $824.86 | 51 | PFIZER INC. ($124.76) |
| 2021 | $380.97 | 24 | Lilly USA, LLC ($74.35) |
| 2020 | $282.29 | 19 | Amgen Inc. ($94.86) |
| 2019 | $691.20 | 51 | Amgen Inc. ($118.95) |
| 2018 | $633.52 | 45 | Novo Nordisk Inc ($126.20) |
| 2017 | $1,170 | 68 | Amgen Inc. ($451.86) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/23/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Diabetes | ||||||
| 05/31/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: VACCINES | ||||||
| 05/25/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Inflammation | ||||||
| 05/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Diabetes | ||||||
| 05/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 05/19/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: Diabetes | ||||||
| 05/15/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Diabetes | ||||||
| 05/11/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Neuroscience | ||||||
| 03/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Diabetes | ||||||
| 02/22/2023 | Merck Sharp & Dohme LLC | STEGLATRO (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 02/02/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Bone Health | ||||||
| 01/17/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Neuroscience | ||||||
| 01/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Inflammation | ||||||
| 12/16/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Diabetes | ||||||
| 12/08/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2022 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiovascular | ||||||
| 11/28/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/17/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/09/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 09/07/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/01/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 08/23/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 08/17/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Gastroenterology | ||||||
| 08/16/2022 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Hepatitis B Vaccine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 939 | 2,942 | $277,577 | $117,085 |
| 2022 | 18 | 699 | 2,988 | $244,308 | $119,649 |
| 2021 | 20 | 803 | 3,324 | $274,927 | $134,020 |
| 2020 | 19 | 928 | 3,228 | $294,138 | $114,990 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 163 | 402 | $136,205 | $47,978 | 35.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 17 | 1,620 | $51,060 | $29,596 | 58.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 128 | $29,889 | $11,470 | 38.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 57 | 57 | $11,420 | $7,118 | 62.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 47 | $8,371 | $3,251 | 38.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $4,078 | $3,097 | 76.0% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 19 | 19 | $3,572 | $2,656 | 74.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 31 | 31 | $3,514 | $2,350 | 66.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 49 | $1,441 | $1,326 | 92.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 15 | $1,269 | $1,033 | 81.4% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 19 | 19 | $1,900 | $739.10 | 38.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 65 | 85 | $935.00 | $714.00 | 76.4% |
| 82306 | Vitamin d-3 level | Office | 2023 | 24 | 24 | $3,600 | $696.24 | 19.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 53 | 56 | $2,800 | $579.60 | 20.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 45 | $2,324 | $488.57 | 21.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 18 | 21 | $1,725 | $473.67 | 27.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 25 | 26 | $1,508 | $427.96 | 28.4% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 31 | 48 | $1,486 | $424.76 | 28.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 31 | 31 | $2,201 | $406.72 | 18.5% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 15 | 21 | $1,218 | $386.07 | 31.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $447.00 | $379.21 | 84.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 13 | 19 | $921.00 | $283.04 | 30.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 16 | 16 | $880.00 | $236.48 | 26.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 13 | $836.00 | $219.03 | 26.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 19 | 28 | $812.00 | $213.08 | 26.2% |
About Dr. Lara Surles, MD
Dr. Lara Surles, MD is a Family Medicine healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285682989.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lara Surles, MD has received a total of $4,208 in payments from pharmaceutical and medical device companies, with $225.14 received in 2023. These payments were reported across 272 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,208).
As a Medicare-enrolled provider, Surles has provided services to 3,369 Medicare beneficiaries, totaling 12,482 services with total Medicare billing of $485,743. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Greenville, NC
- Active Since 05/04/2006
- Last Updated 12/29/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285682989
Products in Payments
- Prolia (Biological) $439.14
- Saxenda (Drug) $243.57
- Aimovig (Biological) $227.22
- Ozempic (Drug) $189.46
- TRULICITY (Drug) $188.65
- Repatha (Biological) $169.76
- Vascepa (Drug) $157.43
- JARDIANCE (Drug) $133.60
- PREVNAR - 13 (Biological) $127.34
- XARELTO (Drug) $124.69
- Livalo (Drug) $114.08
- MOUNJARO (Drug) $110.90
- SHINGRIX (Biological) $109.31
- MYRBETRIQ (Drug) $89.33
- STIOLTO RESPIMAT (Drug) $88.99
- ELIQUIS (Drug) $82.62
- FARXIGA (Drug) $75.78
- PREVNAR 20 (Biological) $74.53
- ENTRESTO (Drug) $73.60
- XIFAXAN (Drug) $65.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greenville
James Franklin, M.d, M.D
Family Medicine — Payments: $114,754
Jeffrey Harris, Md, MD
Family Medicine — Payments: $112,265
Steve Hamberis, M.d, M.D
Family Medicine — Payments: $23,679
Dr. Richard Leland, M.d, M.D
Family Medicine — Payments: $22,628
Dr. Quentin Mewborn, Md, MD
Family Medicine — Payments: $17,870
Eric Faile, M.d, M.D
Family Medicine — Payments: $17,596